GE Healthcare and Vanderbilt University Medical Center are working together to combine immuno-oncology with precision medicine through a five-year collaboration unveiled Jan. 6, to determine which patients might respond optimally to certain immunotherapies and to develop PET imaging tracers to help stratify patients for cancer trials.
The two announced their partnership in tandem with the J.P. Morgan Healthcare Conference Jan. 7-10 in San Francisco. The tie-up will combine GE’s artificial intelligence capabilities with efforts to anonymously...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
